ABVC BIOPHARMA, INC. Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Abvc Biopharma, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Abvc Biopharma, Inc. Current Ratio for the quarter ending September 30, 2024 was 30.6 %, a 39.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 30.6 -20.4 -39.9% Sep 30, 2024
Q2 2024 33.2 -23.5 -41.4% Jun 30, 2024
Q1 2024 34.1 -71.5 -67.7% Mar 31, 2024
Q4 2023 44.1 -97.3 -68.8% Dec 31, 2023
Q3 2023 51 -139 -73.2% Sep 30, 2023
Q2 2023 56.7 -169 -74.8% Jun 30, 2023
Q1 2023 106 -68.4 -39.3% Mar 31, 2023
Q4 2022 141 -4.58 -3.14% Dec 31, 2022
Q3 2022 190 +62.6 +49% Sep 30, 2022
Q2 2022 225 +144 +178% Jun 30, 2022
Q1 2022 174 +113 +184% Mar 31, 2022
Q4 2021 146 +109 +291% Dec 31, 2021
Q3 2021 128 +112 +703% Sep 30, 2021
Q2 2021 81.2 +63.3 +354% Jun 30, 2021
Q1 2021 61.2 +46 +303% Mar 31, 2021
Q4 2020 37.4 +22.2 +146% Dec 31, 2020
Q3 2020 15.9 +3.11 +24.3% Sep 30, 2020
Q2 2020 17.9 +2.3 +14.8% Jun 30, 2020
Q1 2020 15.2 -7.58 -33.3% Mar 31, 2020
Q4 2019 15.2 Dec 31, 2019
Q3 2019 12.8 Sep 30, 2019
Q2 2019 15.6 Jun 30, 2019
Q1 2019 22.8 Mar 31, 2019
Q3 2015 681 Sep 30, 2015
Q2 2015 562 Jun 30, 2015
Q1 2013 2.56 -1.7 -39.9% Mar 31, 2013
Q4 2012 2.82 Dec 31, 2012
Q3 2012 3.35 Sep 30, 2012
Q2 2012 4.17 Jun 30, 2012
Q1 2012 4.26 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.